Skip to main content
. 2020 May 7;20(1):436–446. doi: 10.3892/etm.2020.8726

Figure 1.

Figure 1

Differences in EIF3B expression among subgroups of patients. Boxplots showing differences in EIF3B expression according to (A) tissue type (P<0.001 vs. normal tissue controls), (B) age, (C) sex, (D) histologic grade (P<0.001), (E) histological type, (F) T classification, (G) N classification, (H) M classification, (I) radiation therapy, (J) residual tumor classification, (K) sample type, (L) clinical stage and (M) vital status (P=0.005). EIF3B, eukaryotic translation initiation factor 3 subunit B. G1-4, grade relating to degree of differentiation; T1-4, size and or extension of the primary tumor; TX, tumor could not be assessed; N0, no regional lymph node metastasis; N1, regional lymph node metastasis present; NX, lymph nodes could not be assessed; M0, no distant metastasis; M1, metastasis to distant organs; MX, metastasis could not be assessed; R0, no residual tumor visible under the microscope; R1, residual tumor visible under the microscope; R2, residual tumor visible to the naked eye; RX, residual tumor could not be assessed.